PRESS RELEASE published on 08/28/2025 at 06:59, 7 months 12 days ago Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, enabling patient enrolment in Belgium and collaboration with European centers Biophytis Sarcopenia Phase 3 EMA Approval Belgian Regulatory Approval
BRIEF published on 08/05/2025 at 23:05, 8 months 4 days ago Biophytis Secures €1 Million Non-Dilutive Bond Financing Biophytis Bond Financing Shareholder Impact Non-dilutive OBA101 Program
REGULATED PRESS RELEASE published on 08/05/2025 at 23:00, 8 months 4 days ago Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million Biophytis secures a non-dilutive bond financing line of up to €1 million with Hexagon Capital Fund to support OBA101 program development and strengthen cash position Biophytis Financing Hexagon Capital Fund OBA101 Program Non-dilutive Bond
PRESS RELEASE published on 08/05/2025 at 22:59, 8 months 4 days ago Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million Biophytis secures a non-dilutive bond financing line of up to €1 million from Hexagon Capital Fund. The bonds, with 12% annual interest rate, will mature in 24 months and may be repaid in shares Biophytis Hexagon Capital Fund Non-dilutive Bond Financing 12% Interest Rate Repayment In Shares
BRIEF published on 07/30/2025 at 07:05, 8 months 10 days ago Biophytis Joins Silver Innov' to Boost Silver Economy Initiatives Biophytis Healthcare Innovation Longevity Sarcopenia Silver Innov'
REGULATED PRESS RELEASE published on 07/30/2025 at 07:00, 8 months 10 days ago Biophytis Joins Silver Innov', an Incubator Dedicated to the Silver Economy Biophytis relocates to Silver Innov' in Paris, embracing the silver economy ecosystem for innovation and healthcare in aging, strengthening academic and clinical research collaborations Innovation Biophytis Healthcare Silver Innov Aging
BRIEF published on 07/16/2025 at 07:05, 8 months 24 days ago Biophytis Achieves Legal Victory in Court of Cassation Biophytis Legal Victory Court Of Cassation Negma Group Convertible Bond Dispute
REGULATED PRESS RELEASE published on 07/16/2025 at 07:00, 8 months 24 days ago Biophytis Wins Major Legal Victory Before the French Court of Cassation Biophytis celebrates a major legal win at the French Court of Cassation validating its position in the dispute with Negma Group, a landmark decision protecting the company's interests Biophytis Legal Victory Court Of Cassation Negma Group Landmark Ruling
PRESS RELEASE published on 07/16/2025 at 06:59, 8 months 24 days ago Biophytis Wins Major Legal Victory Before the French Court of Cassation Biophytis celebrates major legal win as French Court of Cassation rules in its favor against Negma Group, marking a turning point in the litigation and validating the company's legal position Biophytis Litigation Legal Victory Negma Group French Court Of Cassation
BRIEF published on 07/15/2025 at 07:05, 8 months 25 days ago Biophytis Partners with Lynx Analytics for AI-Driven Drug Discovery Biophytis Drug Discovery Sarcopenia AI Partnership Lynx Analytics
Published on 04/10/2026 at 00:00, 1 hour ago Redwood AI Announces Upgraded Cloud-Based Reactosphere Platform with Enhanced Security and Expanded Core Capabilities
Published on 04/09/2026 at 23:15, 1 hour 45 minutes ago Digi Power X Enters into Amended and Restated Sales Agreement
Published on 04/09/2026 at 23:00, 2 hours ago Apex Critical Metals to Attend Critical Materials Conference: Aerospace & Defence in Washington, DC
Published on 04/09/2026 at 19:15, 5 hours 45 minutes ago Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 22:00, 3 hours ago Invitation - First Quarter 2026 Trading Update Conference Call
Published on 04/09/2026 at 21:01, 3 hours 59 minutes ago GEVELOT S.A.: PRESS RELEASE CLOSING OF 2025 ACCOUNTS
Published on 04/09/2026 at 20:03, 4 hours 57 minutes ago Annual General Meeting approves all proposals
Published on 04/09/2026 at 18:15, 6 hours 45 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 18:35, 6 hours 25 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 9 hours 2 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 18 hours ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day 6 hours ago Publication of the 2025 Universal Registration Document
